Purification of the human immunodeficiency virus type 1 enhancer and TAR binding proteins EBP-1 and UBP-1.
about
Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifsCharacterization of a family of related cellular transcription factors which can modulate human immunodeficiency virus type 1 transcription in vitroThe human factors YY1 and LSF repress the human immunodeficiency virus type 1 long terminal repeat via recruitment of histone deacetylase 1.Binding of the RING polycomb proteins to specific target genes in complex with the grainyhead-like family of developmental transcription factors.Trans-activation of HIV-1 LTR-directed gene expression by tat requires protein kinase CSp1-dependent activation of a synthetic promoter by human immunodeficiency virus type 1 Tat proteinThe transcription factor LSF: a novel oncogene for hepatocellular carcinomaRole of SP1-binding domains in in vivo transcriptional regulation of the human immunodeficiency virus type 1 long terminal repeatTranscription factor PRDII-BF1 activates human immunodeficiency virus type 1 gene expressionRegulation of human immunodeficiency virus enhancer function by PRDII-BF1 and c-rel gene productsIdentification of genes conferring resistance to 5-fluorouracilIn vitro and in vivo binding of human immunodeficiency virus type 1 Tat protein and Sp1 transcription factorKEGG orthology-based annotation of the predicted proteome of Acropora digitifera: ZoophyteBase - an open access and searchable database of a coral genome.A transdominant tat mutant that inhibits tat-induced gene expression from the human immunodeficiency virus long terminal repeat.NF-kappa B protein purification from bovine spleen: nucleotide stimulation and binding site specificityRepeated B motifs in the human immunodeficiency virus type I long terminal repeat enhancer region do not exhibit cooperative factor binding.Myb protein binds to human immunodeficiency virus 1 long terminal repeat (LTR) sequences and transactivates LTR-mediated transcriptionDifferentiation-dependent human immunodeficiency virus long terminal repeat regulatory elements active in human teratocarcinoma cellsSpecific binding of a HeLa cell nuclear protein to RNA sequences in the human immunodeficiency virus transactivating regionTumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat.Identification of cellular proteins that bind to the human immunodeficiency virus type 1 trans-activation-responsive TAR element RNAIsolation and characterization of the human nucleophosmin/B23 (NPM) gene: identification of the YY1 binding site at the 5' enhancer regionIdentification of the transcriptional unit, structural organization, and promoter sequence of the human sex-determining region Y (SRY) gene, using a reverse genetic approach.Identification of transcriptional suppressor proteins that bind to the negative regulatory element of the human immunodeficiency virus type 1A relational database of transcription factors.Transcriptional activation and chromatin remodeling of the HIV-1 promoter in response to histone acetylation.kappa B elements strongly activate gene expression in non-lymphoid cells and function synergistically with NF1 elements.Lineage-specific and ubiquitous biological roles of the mammalian transcription factor LSFZebrafish grainyhead-like1 is a common marker of different non-keratinocyte epidermal cell lineages, which segregate from each other in a Foxi3-dependent mannercis-acting sequences located downstream of the human immunodeficiency virus type 1 promoter affect its chromatin structure and transcriptional activitySecond-site long terminal repeat (LTR) revertants of replication-defective human immunodeficiency virus: effects of revertant TATA box motifs on virus infectivity, LTR-directed expression, in vitro RNA synthesis, and binding of basal transcription fTAR-independent transactivation of the murine cytomegalovirus major immediate-early promoter by the Tat proteinHuman immunodeficiency virus type 1 infection of the brain.Human immunodeficiency viruses containing heterologous enhancer/promoters are replication competent and exhibit different lymphocyte tropisms.Definition of a lipopolysaccharide-responsive element in the 5'-flanking regions of MuRantes and crg-2.Expression of a human immunodeficiency virus type 1 long terminal repeat/simian virus 40 early region fusion gene in transgenic mice.Cellular factors regulate transactivation of human immunodeficiency virus type 1.Variable role of the long terminal repeat Sp1-binding sites in human immunodeficiency virus replication in T lymphocytes.Adeno-associated virus Rep protein inhibits human immunodeficiency virus type 1 production in human cells.Linker-scanning mutational analysis of the transcriptional activity of the human immunodeficiency virus type 1 long terminal repeat
P2860
Q24317451-7E9397F5-AA7D-4E04-8234-5EA883C92C94Q24324378-EE271FA7-8DBA-4519-A892-49CC653D0449Q24525309-FCD1C7B5-2AB7-4A82-BED1-6B39D28BB8B6Q24540053-C62D4015-B968-4899-A43A-E21D39C045BCQ24556556-614A578C-8751-4FC1-BE16-B83EDDF48E9DQ24561778-75A43CCA-7464-4AA0-934C-03EB3B2F5DF3Q24613885-7716E0F9-D650-4CC1-9B57-7BD4D6030D5BQ24645992-21E834A9-CE25-4794-ABAB-300D9EE54DC1Q24647749-FC83E6AB-DF33-44A0-BF4E-75B4EB549906Q24655654-7ED553B4-A90B-4664-8139-240DFB8518D2Q24655818-F695C147-01FC-46A6-9F13-2B28E12AA7B1Q24655901-9F55BBB3-10D1-4A67-A73A-F2AFD08F1119Q30486269-247032B3-F74C-47F9-9665-CF36BA3B78F4Q33662926-CE0EAD5F-25C5-4B22-97B7-D82B601ABBACQ33676218-4B01E7D8-BAE4-4E63-AA16-34979A6B7654Q33684251-D2C24E6D-61DB-4BE9-A8F9-6E8E79BB97C2Q33850114-B54AA378-DFF1-4372-9E4E-5E1C317F2428Q33931959-E88618DF-70CB-43D0-BDC0-3C0CC021576FQ34284937-0B4A4520-7C69-4DCC-B293-BAB7C3104C4FQ34295016-B5C873F0-6B68-4080-9A79-4ADC06717C92Q34311433-C7ED5D51-5FB1-489F-BDCB-64991C623AC6Q34626996-994FF10B-5ADF-4F6E-91EE-90E150517A1FQ35194262-83BC6A8F-2F87-44FA-822B-1253EE00B6F2Q35792284-F3AD4F11-95F5-454A-91EE-148DFF5C6BC1Q35834981-548A2D51-46C1-4F02-BBB9-2D58530F8EA8Q35845347-93DE6627-74BD-4EF1-83E2-77095AC11681Q35951032-0F9B95F1-151B-462A-AE8B-E84540378729Q35962753-D323638C-AFAE-4823-A2DF-637564B35926Q36128454-2880A5A3-4AF2-4E29-9ABA-EAFB03217308Q36560229-783986AC-5CF7-4399-BCD8-125A7C555FDBQ36633683-6266B8E1-DEBE-4C6F-8CDD-44A75A146419Q36639281-5C6162EB-AC1A-4162-9C75-1DF5F9C53493Q36640545-5D9455F1-6DAE-43DB-845B-116B1DC018A7Q36640831-BE603DB8-31FE-4105-A371-9A5C51836E34Q36651635-98D41248-7E0C-4A13-BCAF-FA1088935FFAQ36680103-E654AE41-3614-494F-9C9F-8EB60AACFD5AQ36682336-155FD7BD-DBD6-460C-83EB-090D5CFD97D3Q36682395-622FA780-03F7-47A5-9CED-150FBEC264B5Q36688082-6E9DD58F-82D6-4F93-8291-8233B00690FBQ36688898-BA0BF0FE-79E0-4E41-87E9-57CD45AC7B57
P2860
Purification of the human immunodeficiency virus type 1 enhancer and TAR binding proteins EBP-1 and UBP-1.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
1988年论文
@zh
1988年论文
@zh-cn
name
Purification of the human immu ...... ding proteins EBP-1 and UBP-1.
@en
Purification of the human immu ...... ding proteins EBP-1 and UBP-1.
@nl
type
label
Purification of the human immu ...... ding proteins EBP-1 and UBP-1.
@en
Purification of the human immu ...... ding proteins EBP-1 and UBP-1.
@nl
prefLabel
Purification of the human immu ...... ding proteins EBP-1 and UBP-1.
@en
Purification of the human immu ...... ding proteins EBP-1 and UBP-1.
@nl
P2093
P2860
P1433
P1476
Purification of the human immu ...... nding proteins EBP-1 and UBP-1
@en
P2093
P2860
P304
P356
10.1002/J.1460-2075.1988.TB03051.X
P407
P577
1988-07-01T00:00:00Z